Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Less than 7% of U.S. seniors get shingles vaccination

Less than 7% of U.S. seniors get shingles vaccination

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

CMS grants Qutenza J-code to NeurogesX

CMS grants Qutenza J-code to NeurogesX

CDC data: Adults remain unvaccinated against preventable infectious illnesses

CDC data: Adults remain unvaccinated against preventable infectious illnesses

Pharmigene receives patent for methods to detect genetic alleles in SJS and TENS

Pharmigene receives patent for methods to detect genetic alleles in SJS and TENS

XenoPort third quarter net loss decreases to $19.9 million

XenoPort third quarter net loss decreases to $19.9 million

Aestus receives $244,000 grant from QTDP program

Aestus receives $244,000 grant from QTDP program

Integra launches XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software

Integra launches XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Stereotactic radiation effective for trigeminal neuralgia

Stereotactic radiation effective for trigeminal neuralgia

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Enrollment complete in Inhibitex's FV-100 Phase II clinical trial in shingles patients

Enrollment complete in Inhibitex's FV-100 Phase II clinical trial in shingles patients

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

AMS enters 10-year contract to supply radiation therapy services at Hospital Santa Paula, Brazil

AMS enters 10-year contract to supply radiation therapy services at Hospital Santa Paula, Brazil

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

Saint Thomas Health Services to offer program for neurosurgical patients’ better care

Study examines impact of microvascular decompression surgery for type 2 diabetes

Study examines impact of microvascular decompression surgery for type 2 diabetes

American Shared Hospital Services second-quarter revenue decreases to $4.16 million

American Shared Hospital Services second-quarter revenue decreases to $4.16 million

Inhibitex reports net loss of $5.6 million for second-quarter 2010

Inhibitex reports net loss of $5.6 million for second-quarter 2010